SE450869B - Material for teckning av sar forsett med aminogrupper som via en dialdehyd eller cyanursyraklorid er kovalent bundet till en biologisk substans. forfarande for dess framstellning - Google Patents

Material for teckning av sar forsett med aminogrupper som via en dialdehyd eller cyanursyraklorid er kovalent bundet till en biologisk substans. forfarande for dess framstellning

Info

Publication number
SE450869B
SE450869B SE8000449A SE8000449A SE450869B SE 450869 B SE450869 B SE 450869B SE 8000449 A SE8000449 A SE 8000449A SE 8000449 A SE8000449 A SE 8000449A SE 450869 B SE450869 B SE 450869B
Authority
SE
Sweden
Prior art keywords
substrate
biological substance
material according
primary
materials
Prior art date
Application number
SE8000449A
Other languages
English (en)
Swedish (sv)
Other versions
SE8000449L (sv
Inventor
Ernest Aubrey Woodroof
Original Assignee
Ernest Aubrey Woodroof
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ernest Aubrey Woodroof filed Critical Ernest Aubrey Woodroof
Publication of SE8000449L publication Critical patent/SE8000449L/xx
Publication of SE450869B publication Critical patent/SE450869B/sv

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/14—Macromolecular materials
    • A61L27/18—Macromolecular materials obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
    • A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
    • A61L15/42—Use of materials characterised by their function or physical properties
    • A61L15/44—Medicaments
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/14—Macromolecular materials
    • A61L27/22—Polypeptides or derivatives thereof, e.g. degradation products
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/14—Macromolecular materials
    • A61L27/22—Polypeptides or derivatives thereof, e.g. degradation products
    • A61L27/222—Gelatin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L33/00—Antithrombogenic treatment of surgical articles, e.g. sutures, catheters, prostheses, or of articles for the manipulation or conditioning of blood; Materials for such treatment
    • A61L33/0005—Use of materials characterised by their function or physical properties
    • A61L33/0011—Anticoagulant, e.g. heparin, platelet aggregation inhibitor, fibrinolytic agent, other than enzymes, attached to the substrate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2310/00—Prostheses classified in A61F2/28 or A61F2/30 - A61F2/44 being constructed from or coated with a particular material
    • A61F2310/00005—The prosthesis being constructed from a particular material
    • A61F2310/00365—Proteins; Polypeptides; Degradation products thereof
    • A61F2310/00383—Gelatin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/20—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices containing or releasing organic materials
    • A61L2300/21—Acids
    • A61L2300/214—Amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/20—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices containing or releasing organic materials
    • A61L2300/22—Lipids, fatty acids, e.g. prostaglandins, oils, fats, waxes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/20—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices containing or releasing organic materials
    • A61L2300/23—Carbohydrates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/20—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices containing or releasing organic materials
    • A61L2300/252—Polypeptides, proteins, e.g. glycoproteins, lipoproteins, cytokines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
    • A61L2300/42—Anti-thrombotic agents, anticoagulants, anti-platelet agents
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S602/00—Surgery: splint, brace, or bandage
    • Y10S602/90—Method of making bandage structure

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Dermatology (AREA)
  • Transplantation (AREA)
  • Hematology (AREA)
  • Materials Engineering (AREA)
  • Engineering & Computer Science (AREA)
  • Surgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Materials For Medical Uses (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
SE8000449A 1979-01-22 1980-01-21 Material for teckning av sar forsett med aminogrupper som via en dialdehyd eller cyanursyraklorid er kovalent bundet till en biologisk substans. forfarande for dess framstellning SE450869B (sv)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US531979A 1979-01-22 1979-01-22

Publications (2)

Publication Number Publication Date
SE8000449L SE8000449L (sv) 1980-07-23
SE450869B true SE450869B (sv) 1987-08-10

Family

ID=21715278

Family Applications (1)

Application Number Title Priority Date Filing Date
SE8000449A SE450869B (sv) 1979-01-22 1980-01-21 Material for teckning av sar forsett med aminogrupper som via en dialdehyd eller cyanursyraklorid er kovalent bundet till en biologisk substans. forfarande for dess framstellning

Country Status (14)

Country Link
US (1) US4828561A (de)
JP (1) JPS55125870A (de)
KR (1) KR830001649A (de)
BE (1) BE881275A (de)
CA (1) CA1169358A (de)
DE (1) DE3002038A1 (de)
DK (1) DK26380A (de)
GB (1) GB2041377B (de)
HK (1) HK56488A (de)
IE (1) IE49066B1 (de)
IT (1) IT1129710B (de)
LU (1) LU82102A1 (de)
NL (1) NL8000330A (de)
SE (1) SE450869B (de)

Families Citing this family (78)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE456347B (sv) * 1982-02-09 1988-09-26 Ird Biomaterial Ab Ytmodifierat fast substrat samt forfarande for framstellning derav
SE8200751L (sv) * 1982-02-09 1983-08-10 Olle Larm Forfarande for kovalent koppling for framstellning av konjugat och hervid erhallna produkter
US4588624A (en) * 1982-05-14 1986-05-13 Astra Meditec Ab Articles exhibiting a biocompatible surface layer
JPS5938150U (ja) * 1982-09-03 1984-03-10 株式会社クボタ 不整地走行用運搬車
SE446688C (sv) * 1982-09-14 1989-10-16 Magnus Hoeoek Medel foer avlaegsnande av mikroorganismer fraan vaevnader, vilket bestaar av ett protein som kan bindas till mikroorganismerna
GB8401534D0 (en) * 1984-01-20 1984-02-22 Royal Free Hosp School Med Biocompatible surfaces
DE3639561A1 (de) * 1986-11-20 1988-06-01 Baumann Hanno Verfahren zur herstellung von nicht-thrombogenen substraten
JPS6425870A (en) * 1987-04-30 1989-01-27 Ajinomoto Kk Support for anastomosis or bonding of living body
US4789601A (en) * 1987-05-04 1988-12-06 Banes Albert J Biocompatible polyorganosiloxane composition for cell culture apparatus
JP2561309B2 (ja) * 1988-03-28 1996-12-04 テルモ株式会社 医療用材料およびその製造方法
US5338770A (en) * 1988-06-08 1994-08-16 Cardiopulmonics, Inc. Gas permeable thrombo-resistant coatings and methods of manufacture
US5262451A (en) * 1988-06-08 1993-11-16 Cardiopulmonics, Inc. Multifunctional thrombo-resistant coatings and methods of manufacture
US5182317A (en) * 1988-06-08 1993-01-26 Cardiopulmonics, Inc. Multifunctional thrombo-resistant coatings and methods of manufacture
US5342693A (en) * 1988-06-08 1994-08-30 Cardiopulmonics, Inc. Multifunctional thrombo-resistant coating and methods of manufacture
JPH0221875A (ja) * 1988-07-11 1990-01-24 Terumo Corp 医療用材料ならびに医療用器具
US5126140A (en) * 1988-08-03 1992-06-30 New England Deaconess Hospital Corporation Thrombomodulin-coated bicompatible substance
US5019393A (en) * 1988-08-03 1991-05-28 New England Deaconess Hospital Corporation Biocompatible substance with thromboresistance
US5281662A (en) * 1988-08-03 1994-01-25 New England Deaconess Hospital Corporation Anthraquinone dye treated materials
FR2649888B1 (fr) * 1989-07-18 1994-08-26 Exsymol Sa Produits pour applications cutanees, a effets cosmetiques ou/et therapeutiques
GB9022938D0 (en) * 1990-10-22 1990-12-05 Biocompatibles Ltd Non-thrombogenic surfaces
ES2103313T3 (es) * 1990-11-05 1997-09-16 Biocompatibles Ltd Esteres de acido fosforico y su utilizacion en la preparacion de superficies biocompatibles.
DE69332959T2 (de) * 1992-02-04 2004-05-13 Baxter International Inc., Deerfield Lösungen für die Peritonealdialyse und deren Verwendung zum Verringern von Schädigungen an mesothelialen Zellen
CA2102234C (en) * 1992-02-04 2008-11-18 Andrzej Breborowicz Peritoneal dialysis composition and method usable during and after peritonitis
US5391203A (en) * 1992-04-13 1995-02-21 Scott P. Bartlett Method of draining and filling soft tissue implant
AU4381793A (en) * 1992-05-20 1993-12-13 Cytrx Corporation Gel composition for implant prosthesis and method of use
DE4217917A1 (de) * 1992-05-30 1993-12-02 Job Prof Dr Med Harenberg Immobilisation von chemisch kovalent gebundenem Heparin an Polymere mit Arylresten im Polymer
US5342387A (en) * 1992-06-18 1994-08-30 American Biomed, Inc. Artificial support for a blood vessel
ES2104543T3 (es) * 1995-06-07 2002-08-16 Shiro Yamada Pelo artificial para la implantacion de cabello y procedimiento para la produccion del mismo.
MX9602398A (es) * 1995-06-23 1997-02-28 Kimberly Clark Co Material polimerico modificado teniendo humectabilidad mejorada.
US5891196A (en) * 1997-04-16 1999-04-06 Baxter International Inc. Method for actively binding heparin to crosslinked biological tissues
US6776792B1 (en) * 1997-04-24 2004-08-17 Advanced Cardiovascular Systems Inc. Coated endovascular stent
IL133105A (en) * 1997-06-04 2004-09-27 Debio Rech Pharma Sa Implants for controlled release of pharmaceutically active principles and method for making same
US6197289B1 (en) 1997-07-01 2001-03-06 Terumo Cardiovascular Systems Corporation Removal of biologically active agents
US6146771A (en) 1997-07-01 2000-11-14 Terumo Cardiovascular Systems Corporation Process for modifying surfaces using the reaction product of a water-insoluble polymer and a polyalkylene imine
AU6472900A (en) * 1999-08-10 2001-03-13 Seikagaku Corporation Glycosaminoglycan derivatives and utilization thereof
DE60115712T2 (de) 2000-08-23 2006-09-07 Thoratec Corp., Pleasanton Beschichtete gefässtransplantate und verwendungsverfahren
US6783793B1 (en) 2000-10-26 2004-08-31 Advanced Cardiovascular Systems, Inc. Selective coating of medical devices
US6565659B1 (en) 2001-06-28 2003-05-20 Advanced Cardiovascular Systems, Inc. Stent mounting assembly and a method of using the same to coat a stent
US9101536B2 (en) * 2002-08-06 2015-08-11 Matrix Medical Llc Biocompatible phase invertable proteinaceous compositions and methods for making and using the same
US10098981B2 (en) 2002-08-06 2018-10-16 Baxter International Inc. Biocompatible phase invertable proteinaceous compositions and methods for making and using the same
DE20306637U1 (de) * 2003-04-28 2003-06-26 Gfe Medizintechnik Gmbh Weichteilimplantate wie Brustimplantat, Wadenmuskelprothese o.dgl.
US7198675B2 (en) 2003-09-30 2007-04-03 Advanced Cardiovascular Systems Stent mandrel fixture and method for selectively coating surfaces of a stent
US7563324B1 (en) 2003-12-29 2009-07-21 Advanced Cardiovascular Systems Inc. System and method for coating an implantable medical device
US7553377B1 (en) 2004-04-27 2009-06-30 Advanced Cardiovascular Systems, Inc. Apparatus and method for electrostatic coating of an abluminal stent surface
US7678767B2 (en) * 2004-06-16 2010-03-16 Pneumrx, Inc. Glue compositions for lung volume reduction
US7553810B2 (en) 2004-06-16 2009-06-30 Pneumrx, Inc. Lung volume reduction using glue composition
EP1773225B1 (de) * 2004-06-16 2019-05-01 PneumRx, Inc. System zur verrringerung des intrabronchialen lungenvolumens
US7394943B2 (en) * 2004-06-30 2008-07-01 Applera Corporation Methods, software, and apparatus for focusing an optical system using computer image analysis
US20060058891A1 (en) * 2004-09-16 2006-03-16 Lesh Michael D Transformable tissue bulking device
US20060058890A1 (en) * 2004-09-16 2006-03-16 Lesh Michael D Methods for soft tissue augmentation
WO2006034077A1 (en) * 2004-09-16 2006-03-30 Juva Medical, Inc. Tissue augmentation device
US20060058892A1 (en) * 2004-09-16 2006-03-16 Lesh Michael D Valved tissue augmentation implant
US7244270B2 (en) * 2004-09-16 2007-07-17 Evera Medical Systems and devices for soft tissue augmentation
US7641688B2 (en) 2004-09-16 2010-01-05 Evera Medical, Inc. Tissue augmentation device
US7632307B2 (en) 2004-12-16 2009-12-15 Advanced Cardiovascular Systems, Inc. Abluminal, multilayer coating constructs for drug-delivery stents
US7867547B2 (en) 2005-12-19 2011-01-11 Advanced Cardiovascular Systems, Inc. Selectively coating luminal surfaces of stents
US8069814B2 (en) 2006-05-04 2011-12-06 Advanced Cardiovascular Systems, Inc. Stent support devices
US8603530B2 (en) 2006-06-14 2013-12-10 Abbott Cardiovascular Systems Inc. Nanoshell therapy
US8048448B2 (en) 2006-06-15 2011-11-01 Abbott Cardiovascular Systems Inc. Nanoshells for drug delivery
US8017237B2 (en) 2006-06-23 2011-09-13 Abbott Cardiovascular Systems, Inc. Nanoshells on polymers
US20100297218A1 (en) * 2006-09-20 2010-11-25 Pneumrx, Inc. Tissue adhesive compositions and methods thereof
WO2008076383A2 (en) * 2006-12-18 2008-06-26 Med Institute Inc. Stent graft with releasable therapeutic agent
JP5116010B2 (ja) * 2007-03-13 2013-01-09 独立行政法人産業技術総合研究所 薬物徐放能を備えた抗血栓性材料
US8048441B2 (en) 2007-06-25 2011-11-01 Abbott Cardiovascular Systems, Inc. Nanobead releasing medical devices
KR101565624B1 (ko) 2007-12-20 2015-11-03 노파르티스 아게 콘택트 렌즈의 제조 방법
US20090198329A1 (en) 2008-02-01 2009-08-06 Kesten Randy J Breast implant with internal flow dampening
US20090198331A1 (en) * 2008-02-01 2009-08-06 Kesten Randy J Implantable prosthesis with open cell flow regulation
US20090234305A1 (en) * 2008-03-15 2009-09-17 Ernest Aubrey Woodroof Temporary skin substitute comprised of biological compounds of plant and animal origins
US20100030170A1 (en) * 2008-08-01 2010-02-04 Keith Alan Keller Absorptive Pad
US9199016B2 (en) 2009-10-12 2015-12-01 New Health Sciences, Inc. System for extended storage of red blood cells and methods of use
US11284616B2 (en) 2010-05-05 2022-03-29 Hemanext Inc. Irradiation of red blood cells and anaerobic storage
DK2516570T3 (en) * 2009-12-23 2017-05-01 Dsm Ip Assets Bv PROCEDURE FOR ACTIVATING SURFACES OF SILICONE RUBBER
US20110155141A1 (en) * 2009-12-28 2011-06-30 Sawyer Lawrence H Wearable Article That Stiffens Upon Sudden Force
EP3268015B1 (de) 2015-03-10 2021-10-13 Hemanext Inc. Einweg-kits zur sauerstoffreduktion, vorrichtungen und verfahren zur verwendung davon
CN114748503A (zh) 2015-05-18 2022-07-15 希玛奈克斯特股份有限公司 储存全血的方法及其组合物
MX2018014530A (es) 2016-05-27 2019-02-21 New Health Sciences Inc Almacenamiento anaerobico de sangre y metodo de inactivacion de patogenos.
JP7405866B2 (ja) * 2019-05-13 2023-12-26 オーブリー ウッドルーフ、イー． 皮膚代替物に対する接着性、伸縮性、及び適合性が向上した皮膚代替物
WO2023181081A1 (en) * 2022-03-21 2023-09-28 Haskoli Islands Surface activation of silicone

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3457098A (en) * 1966-08-18 1969-07-22 Us Health Education & Welfare Nonthrombogenic plastic surfaces and preparation thereof
US3846353A (en) * 1970-06-08 1974-11-05 Department Of Health Education Nonthrombogenic plastic material and method for making the same
DE2148011C3 (de) * 1970-10-05 1978-11-09 Aminkemi Ab Verfahren zum Herstellen nichtthrombogener Kunststoffoberflächen
US3826678A (en) * 1972-06-06 1974-07-30 Atomic Energy Commission Method for preparation of biocompatible and biofunctional materials and product thereof
US4001583A (en) * 1974-10-04 1977-01-04 Barrett M James Covalently bound biological substances to plastic materials and use in radioassay
SE425372B (sv) * 1977-07-18 1982-09-27 Ird Biomaterial Ab Sett att heparinisera en elektriskt laddad yta pa en medecinsk artikel avsedd att komma i kontakt med blod och medel for utforande av settet

Also Published As

Publication number Publication date
DK26380A (da) 1980-07-23
DE3002038C2 (de) 1990-12-06
HK56488A (en) 1988-08-05
JPS55125870A (en) 1980-09-29
SE8000449L (sv) 1980-07-23
KR830001649A (ko) 1983-05-18
IE49066B1 (en) 1985-07-24
LU82102A1 (fr) 1980-04-23
IT1129710B (it) 1986-06-11
GB2041377B (en) 1983-09-28
IT8019372A0 (it) 1980-01-22
JPS6137952B2 (de) 1986-08-26
CA1169358A (en) 1984-06-19
DE3002038A1 (de) 1980-07-31
BE881275A (nl) 1980-05-16
NL8000330A (nl) 1980-07-24
IE800110L (en) 1980-07-22
US4828561A (en) 1989-05-09
GB2041377A (en) 1980-09-10

Similar Documents

Publication Publication Date Title
SE450869B (sv) Material for teckning av sar forsett med aminogrupper som via en dialdehyd eller cyanursyraklorid er kovalent bundet till en biologisk substans. forfarande for dess framstellning
US4725279A (en) Bio compatible and blood compatible materials and methods
US4820302A (en) Bio compatible and blood compatible materials and methods
US4060081A (en) Multilayer membrane useful as synthetic skin
US4831065A (en) Antithrombogenic, non-calcifying material and method of making articles for medical purposes
US3800792A (en) Laminated collagen film dressing
US7476398B1 (en) Corneal implant and uses thereof
RU2438714C2 (ru) Биологическая заплата и способ ее изготовления
EP0177573A1 (de) Biologisch degradierbare form und verfahren zu deren herstellung.
AU2006329153B2 (en) Biological wound dressing and method of making
EP3773766B1 (de) Nanofaserverstärkte medizinische hydrogel-wundauflagen
CA2321890A1 (en) Sulphated hyaluronic acid and sulphated derivatives thereof covalently bound to polyurethanes, and the process for their preparation
EP0089152B1 (de) Hydrophiler Biopolymer-Copolyelektrolyt und ihn enthaltender bioresorbierbarer Wundverband
JP3521226B2 (ja) 架橋複合生体材料
US7576051B2 (en) Wound dressing for accelerating epidermal regeneration
US20090230592A1 (en) Laser-Perforated Skin Substitute
JPS6379588A (ja) 細胞培養用基材およびその製造方法
Doillon Skin replacement using collagen extracted from bovine hide
JPH05184662A (ja) 人工皮膚およびその製造法
JPH0481466B2 (de)
JPH01104257A (ja) 人工皮膚およびその製造方法
JPS63115562A (ja) 創傷被覆材

Legal Events

Date Code Title Description
NAL Patent in force

Ref document number: 8000449-2

Format of ref document f/p: F

NUG Patent has lapsed

Ref document number: 8000449-2

Format of ref document f/p: F